ViewFinder utilizes advanced machine learning algorithms to enhance the interpretation of 3D X-ray images for breast cancer diagnosis. The platform provides radiologists with improved accuracy and efficiency in identifying potential malignancies, ensuring timely and effective patient care.
Funding
$760.8K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Radiologists face challenges in accurately interpreting 3D X-ray images for breast cancer diagnosis, potentially leading to missed or delayed detection of malignancies. The complexity of these images and the subtle nature of cancerous indicators can result in increased reading times and diagnostic uncertainty.
Solution
ViewFinder is a machine learning-powered platform designed to improve the accuracy and efficiency of 3D X-ray image interpretation for breast cancer diagnosis. By applying advanced algorithms, ViewFinder enhances the visualization and analysis of potential malignancies, assisting radiologists in making more informed decisions. The platform aims to reduce diagnostic errors, accelerate the reading process, and ultimately improve patient outcomes through earlier and more accurate detection of breast cancer.
Target Audience
The primary target audience includes radiologists, breast imaging specialists, and healthcare providers involved in breast cancer screening and diagnosis.
Features
- Automated detection of suspicious areas within 3D X-ray images
- Enhanced visualization tools for improved image clarity and detail
- Machine learning algorithms trained on a large dataset of breast X-rays
- Integration with existing radiology workflows and systems
- Customizable reporting features for streamlined communication of findings
- Quantitative analysis of lesion characteristics to aid in differentiation